// App-Quantinova.ai

29095 : TRIPLE THERAPY WITH ASPIRIN, PRASUGREL AND VITAMIN K ANTAGONISTS IN PATIENTS WITH DRUG ELUTING STENT IMPLANTATION AND AN INDICATION FOR ORAL ANTICOAGULATION

Researchers

Presenter

  • Nikolaus Sarafoff

Principal Investigators

  • Amadea Martischnig

  • Jill Wealer

  • Katharina Mayer

  • Julinda Mehilli

  • Dirk Sibbing

  • Adnan Kastrati

  • Deutsches Herzzentrum

Medical Centers

  • Technical Univ of Munich, Munich, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Ischemic stroke

  • Venous thrombosis

  • Stroke

Biomarkers

  • Dopamine transporter

Drug/Treatment

  • Clopidogrel bisulfate

  • Prasugrel

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved